Kezdőlap・Részvénylista・Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corp

Lezárt

SzektorEgészségügy

17.05 -3.51

Vétel Eladás

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

16.98

Maximum

17.6

Fő mutatók
By Trading Economics
Bevétel	9.2M 4.6M
Értékesítés	27M 419M
Egy részvényre jutó nyereség	0.56
Profit margin	1.103
Munkavállalók	4,427
EBITDA	-35M 28M

Ajánlások
By TipRanks
Ajánlások	Semleges
12 hónapos előrejelzés	+9.11% upside

Osztalékok
By Acuity
Következő eredményjelentés	2026. okt. 29.

Piaci statisztika
By TradingEconomics
Piaci kapitalizáció	-129M 1.4B
Előző nyitás	20.56
Előző zárás	17.05

Hangulat hírek alapján

By Acuity

25%

75%

72 / 340 Rangsor szerint Healthcare

Integra LifeSciences Holdings Corp Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. aug. 6. 19:36 UTC

Integra Lifesciences Holdings Corp shares are lower today, continuing a decline since Wednesday's close. The stock remains below its 20-day moving average.

2026. aug. 5. 19:36 UTC

Integra Lifesciences Holdings Corp shares are lower today, continuing a decline since Tuesday's close. The stock remains significantly below its 20-day moving average.

2026. aug. 4. 19:46 UTC

Integra Lifesciences Holdings Corp shares are lower during Tuesday's session, approximately 3.60% below the 20-day moving average, with no specific news identified.

2026. aug. 3. 20:51 UTC

Integra Lifesciences Holdings Corp gains in after-market hours, reflecting broader market optimism despite no specific company news. Major indices also show significant increases.

2026. júl. 31. 19:46 UTC

Integra Lifesciences Holdings Corp shares are lower during Friday's session, trading near the lower end of their one-month range with no specific news identified.

2026. júl. 30. 17:41 UTC

Integra Lifesciences Holdings Corp shares are higher today, despite earlier session pullbacks. No specific news was identified to explain the movement.

2026. júl. 29. 21:01 UTC

Integra Lifesciences shares are lower in after-market hours, reflecting a broader decline in U.S. equities amid rising oil prices and geopolitical tensions.

2026. júl. 28. 20:03 UTC

News

Shares of Integra Lifesciences Holdings are higher, supported by UBS's Neutral rating and price target of $19 amid broader Health Care Equipment gains.

2026. júl. 27. 19:51 UTC

Integra Lifesciences Holdings Corp shares are lower today amid notable volatility, despite remaining near the upper end of their one-month trading range.

2026. júl. 24. 19:02 UTC

News

Integra Lifesciences shares are higher today, following a downgrade from Wall Street Zen and a price target increase from Truist Financial to $19.00.

2026. júl. 21. 18:46 UTC

Integra Lifesciences Holdings shares are higher amid broader market recovery, despite a slight pullback from earlier gains. The stock remains above its 20-day moving average.

2026. júl. 20. 19:26 UTC

News

Integra Lifesciences Holdings is lower amid broader market pressure from rising Treasury yields. Investors await upcoming quarterly results after exceeding earnings expectations.

Társak összehasonlítása

Árváltozás

Integra LifeSciences Holdings Corp Előrejelzés

Célár

By TipRanks

9.11% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 19.29 USD 9.11%

Magas 25 USD

Alacsony 17 USD

9 Wall Street elemző 12 hónapos célárain alapulva a(z)Integra LifeSciences Holdings Corp termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Semleges

9 ratings

Vétel

Tartás

Eladás

9 Wall Street elemző célárain alapulva a(z)Integra LifeSciences Holdings Corp termékhez az elmúlt 3 hónapban.

Hangulat

By Acuity

72 / 340 Rangsor szerint Egészségügy

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

Rólunk Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.